![]() |
Name |
secoemestrin D
|
Molecular Formula | C27H24N2O8S4 | |
IUPAC Name* |
[12-[(4-hydroxyphenyl)methyl]-18-methyl-11,17-dioxo-5-oxa-13,14,15,16-tetrathia-10,18-diazatetracyclo[10.4.2.01,10.03,9]octadeca-3,6-dien-8-yl]3-hydroxy-4-methoxybenzoate
|
|
SMILES |
COc1ccc(C(=O)OC2C=COC=C3CC45SSSSC(Cc6ccc(O)cc6)(C(=O)N4C32)N(C)C5=O)cc1O
|
|
InChI |
InChI=1S/C27H24N2O8S4/c1-28-24(33)27-13-17-14-36-10-9-21(37-23(32)16-5-8-20(35-2)19(31)11-16)22(17)29(27)25(34)26(28,38-40-41-39-27)12-15-3-6-18(30)7-4-15/h3-11,14,21-22,30-31H,12-13H2,1-2H3/t21-,22-,26+,27+/m0/s1
|
|
InChIKey |
ONXASDRNDFVLMR-DOQQYFFYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 632.76 | ALogp: | 4.5 |
HBD: | 2 | HBA: | 12 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 125.8 | Aromatic Rings: | 7 |
Heavy Atoms: | 41 | QED Weighted: | 0.342 |
Caco-2 Permeability: | -5.346 | MDCK Permeability: | 0.00001570 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.773 | 20% Bioavailability (F20%): | 0.987 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.729 | Plasma Protein Binding (PPB): | 91.23% |
Volume Distribution (VD): | 0.787 | Fu: | 21.28% |
CYP1A2-inhibitor: | 0.152 | CYP1A2-substrate: | 0.119 |
CYP2C19-inhibitor: | 0.99 | CYP2C19-substrate: | 0.743 |
CYP2C9-inhibitor: | 0.972 | CYP2C9-substrate: | 0.87 |
CYP2D6-inhibitor: | 0.758 | CYP2D6-substrate: | 0.107 |
CYP3A4-inhibitor: | 0.968 | CYP3A4-substrate: | 0.973 |
Clearance (CL): | 8.576 | Half-life (T1/2): | 0.12 |
hERG Blockers: | 0.127 | Human Hepatotoxicity (H-HT): | 0.094 |
Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.921 | Maximum Recommended Daily Dose: | 0.917 |
Skin Sensitization: | 0.339 | Carcinogencity: | 0.98 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.839 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002193 | ![]() |
0.367 | D0Q9ON | ![]() |
0.266 | ||
ENC005414 | ![]() |
0.326 | D07MGA | ![]() |
0.255 | ||
ENC003597 | ![]() |
0.320 | D01XBA | ![]() |
0.250 | ||
ENC000134 | ![]() |
0.318 | D05DVP | ![]() |
0.247 | ||
ENC002571 | ![]() |
0.315 | D0S5RZ | ![]() |
0.245 | ||
ENC003721 | ![]() |
0.313 | D0JC9N | ![]() |
0.241 | ||
ENC002587 | ![]() |
0.311 | D0L0SW | ![]() |
0.241 | ||
ENC003498 | ![]() |
0.310 | D0JY8T | ![]() |
0.239 | ||
ENC002376 | ![]() |
0.310 | D0VU8Q | ![]() |
0.238 | ||
ENC002900 | ![]() |
0.308 | D06HBQ | ![]() |
0.237 |